Metronidazole Encephalopathy EEG Features: A Case Report with Systematic Review of the Literature

Lorenzo Ricci1, Francesco Motolese1, Mario Tombini1

  • 1Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, University Campus Bio-Medico of Rome, via Álvaro del Portillo 21, 00128 Rome, Italy.

Brain Sciences
|April 16, 2020
PubMed

Insights

Metronidazole-induced encephalopathy (MIE) is a rare neurological condition. This study details a unique electroencephalography (EEG) pattern observed during MIE, potentially aiding diagnosis.

Area of Science:

  • Neurology
  • Neurophysiology
  • Toxicology

Background:

  • Metronidazole-induced encephalopathy (MIE) is a rare iatrogenic condition.
  • Diagnosis relies on clinical presentation (encephalopathy, seizures, cerebellar signs) and MRI, as EEG findings are poorly described.
  • Electroencephalography (EEG) plays a limited role in current MIE diagnostic criteria.

Purpose of the Study:

  • To present a detailed longitudinal EEG assessment in a patient with MIE.
  • To describe a peculiar and evolving EEG pattern associated with metronidazole toxicity.
  • To explore the potential of this EEG pattern as a neurophysiological correlate of cerebellar encephalopathy.

Main Methods:

  • Longitudinal EEG monitoring of a single patient with confirmed MIE.
  • Detailed analysis of EEG pattern evolution during the acute phase of encephalopathy.
  • Systematic literature review on EEG findings in metronidazole-induced encephalopathy.

Main Results:

  • The patient exhibited a unique EEG pattern characterized by monomorphic, sharply contoured, symmetric frontal theta activity.
  • This EEG pattern demonstrated anterior-posterior progression and correlated with clinical worsening.
  • The described EEG activity evolved in parallel with the patient's clinical recovery.

Conclusions:

  • The peculiar EEG pattern observed may represent a distinct neurophysiological marker for MIE.
  • Further research is needed to validate this EEG finding as a diagnostic correlate for 'cerebellar encephalopathy'.
  • This case highlights the importance of considering EEG in the comprehensive evaluation of MIE.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
528
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
633
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K